Neuroblastoma Research Studies

< Back to Pediatric Cancer Research Studies Page

Neuroblastoma New Diagnosis

ANBL1232: Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma

  • Conditions: Neuroblastoma New Diagnosis

PURPOSE: This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma. Sometimes a tumor may not need treatment until it progresses. In this case, observation may be sufficient. Measuring biomarkers in ...More

Contact Us

Contact us.

To learn more about available neuroblastoma clinical trials, contact us at cancer@cchmc.org or 513-636-2799.